Ineteconomics
Who Pays for New Drugs?
Drug development can better serve public needs—especially in neglected diseases—by reimagining the balance between government, private industry, and nonprofit models.
Can Data Rebuild the American Dream?
Big data reveals where opportunity thrives—and where it vanishes—offering powerful tools to reverse the decline in economic mobility.
Explosive New Book Argues Facebook Is a Global Engine of Harm and Corruption. Is Reform Possible?
Sara Wynn-Williams, defying Facebook’s attempts to silence her, reveals the company’s toxic culture and global damage, exposing unethical practices and a profit-at-any-cost approach. The key question she leaves us with: How can this be changed?
Early in her chilling account of life as a Facebook executive, Sara Wynn-Williams drops an intriguing detail: Mark Zuckerberg’s favorite president. The young founder – still in his twenties at the time -- picks Andrew Jackson, because he “got stuff done.”
Who Controls the Future of Work?
AI has the potential to fuel historic levels of wealth concentration, leaving workers behind while a handful of companies profit. Or we can choose policies that steer us toward shared prosperity. The future is still up to us.
Leadership in the Senate: New Boss Same as the Old Boss?
To understand politics in America, follow the money. When we do, we find good cause to expect McConnell’s shadow to live long beyond his tenure.
The Supreme Court and the Dismantling of Government Power
Recent rulings are rolling back federal regulatory authority, echoing past constitutional battles over administrative governance.
Altmetric Reports that Fred Ledley's INET-Funded Research Is in the Top 1% of all Papers Published by JAMA Health Forum
Altmetric
Fred Ledley's INET-funded research, which has been published as an INET working paper, documents that the US Government is the first investor in practically all crucial biopharmaceutical innovation.
“A Generational Loss of Talent” - Scientist Warns Funding Cuts in Science, Tech, and Health Undermine U.S. Leadership
Phillip Alvelda, a scientist and entrepreneur with past roles at NASA and DARPA, sounds the alarm on cuts that threaten the innovative capacities that have made America a global powerhouse.
const trinityScript = document.createElement('script'); trinityScript.setAttribute('fetchpriority', 'high'); trinityScript.src = 'https://trinitymedia.ai/player/trinity/2900011009/?pageURL=' + encodeURIComponent(window.location.href); document.currentScript.parentNode.insertBefore(trinityScript, document.currentScript);
Pages
